NIASPAN Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Niaspan, and what generic alternatives are available?

Niaspan is a drug marketed by Abbvie and is included in one NDA.

The generic ingredient in NIASPAN is niacin. There are fourteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the niacin profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Niaspan

A generic version of NIASPAN was approved as niacin by BARR on April 14^th, 2005.

Sign Up

Summary for NIASPAN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	212
Clinical Trials:	45
Patent Applications:	4,162
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for NIASPAN
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for NIASPAN
What excipients (inactive ingredients) are in NIASPAN?	NIASPAN excipients list
DailyMed Link:	NIASPAN at DailyMed

Drug patent expirations by year for NIASPAN

Recent Clinical Trials for NIASPAN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cortria Corporation	Phase 1
PPD	Phase 1
Pharmena North America	Phase 1

See all NIASPAN clinical trials

US Patents and Regulatory Information for NIASPAN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-004	Jul 28, 1997		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-003	Jul 28, 1997		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-001	Jul 28, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-002	Jul 28, 1997		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	NIASPAN TITRATION STARTER PACK	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-005	Jul 28, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NIASPAN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-003	Jul 28, 1997	⤷ Sign Up	⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-003	Jul 28, 1997	⤷ Sign Up	⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-002	Jul 28, 1997	⤷ Sign Up	⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-001	Jul 28, 1997	⤷ Sign Up	⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-004	Jul 28, 1997	⤷ Sign Up	⤷ Sign Up
Abbvie	NIASPAN	niacin	TABLET, EXTENDED RELEASE;ORAL	020381-004	Jul 28, 1997	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for NIASPAN

See the table below for patents covering NIASPAN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
World Intellectual Property Organization (WIPO)	9839001		⤷ Sign Up
Australia	6454598		⤷ Sign Up
Canada	2283322	KIT DE DEPART CONTENANT DES COMPOSITIONS D'ACIDE NICOTINIQUE (STARTER KIT CONTAINING NICOTINIC ACID COMPOSITIONS)	⤷ Sign Up
Canada	2574987		⤷ Sign Up
European Patent Office	0969837		⤷ Sign Up
Germany	69829042		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for NIASPAN

Recent Clinical Trials for NIASPAN

Make Better Decisions: Try a trial or see plans & pricing